###begin article-title 0
###xml 117 122 <span type="species:ncbi:9606">Women</span>
Role of Haptoglobin in Polycystic Ovary Syndrome (PCOS), Obesity and Disorders of Glucose Tolerance in Premenopausal Women
###end article-title 0
###begin p 1
Conceived and designed the experiments: FAB JLSM HFEM. Performed the experiments: FAB MAMG MLR NP HFEM. Analyzed the data: FAB MAMG MLR NP JLSM HFEM. Contributed reagents/materials/analysis tools: NP JLSM HFEM. Wrote the paper: FAB MAMG MLR JLSM HFEM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
Hp2 alleles of the haptoglobin alpha-chain polymorphism reduce the anti-oxidant properties and increase the pro-inflammatory actions of this acute-phase protein in a gene-dosage fashion. We hypothesized that the haptoglobin polymorphism might contribute to the increased oxidative stress and low-grade chronic inflammation frequently associated with polycystic ovary syndrome, obesity, and abnormalities of glucose tolerance.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 405 406 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 403 406 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 429 430 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 496 497 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 154 159 <span type="species:ncbi:9606">women</span>
###xml 201 206 <span type="species:ncbi:9606">women</span>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
Serum haptoglobin and the haptoglobin alpha-chain polymorphism were determined in 141 patients with polycystic ovary syndrome and 102 non-hyperandrogenic women. Of the whole group of 243 premenopausal women, 117 were obese and 51 showed abnormal glucose tolerance. Although serum haptoglobin concentrations were similar in PCOS patients and controls, the former presented with an increased frequency of Hp2 alleles (62% vs. 52%, P = 0.023). Circulating haptoglobin levels increased with obesity (P<0.001), yet no association was found between obesity and haptoglobin genotypes. No differences were observed in haptoglobin levels or genotype frequencies depending on glucose tolerance. Fifty percent of the variation in serum haptoglobin concentrations was explained by the variability in serum C-reactive protein concentrations, BMI, insulin sensitivity and haptoglobin genotypes.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 50 55 <span type="species:ncbi:9606">women</span>
###xml 395 403 <span type="species:ncbi:9606">patients</span>
Serum haptoglobin concentrations in premenopausal women are largely dependent on the haptoglobin polymorphism and on the presence of obesity, with insulin resistance and chronic inflammation possibly modulating this relationship. The association of polycystic ovary syndrome with Hp2 alleles suggests that the anti-oxidant and anti-inflammatory properties of haptoglobin may be reduced in these patients.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Azziz1">[1]</xref>
###xml 176 179 176 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Azziz2">[2]</xref>
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-EscobarMorreale1">[3]</xref>
###xml 249 252 249 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Codner1">[4]</xref>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Conn1">[5]</xref>
###xml 433 436 433 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-AlvarezBlasco1">[6]</xref>
###xml 478 481 478 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-EscobarMorreale2">[7]</xref>
###xml 514 517 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-EscobarMorreale3">[8]</xref>
###xml 536 539 536 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Sabuncu1">[9]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Legro1">[10]</xref>
###xml 165 170 <span type="species:ncbi:9606">women</span>
###xml 356 364 <span type="species:ncbi:9606">patients</span>
Polycystic ovary syndrome (PCOS), a very prevalent syndrome characterized by the association of hyperandrogenism with chronic ovulatory dysfunction in premenopausal women [1], [2], is among the most common metabolic associations of both type 1 [3], [4] and type 2 diabetes mellitus [5]. Hyperinsulinism and insulin resistance are frequent findings in PCOS patients, and these traits have cause-consequence relationships with obesity [6], increased serum ferritin concentrations [7], low-grade chronic inflammation [8], oxidative stress [9], and increased cardiovascular risk [10].
###end p 9
###begin p 10
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-EscobarMorreale2">[7]</xref>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HFE</italic>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-BotellaCarretero1">[11]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-LuqueRamirez1">[12]</xref>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 166 171 <span type="species:ncbi:9606">women</span>
We have shown that serum ferritin concentrations are increased in PCOS patients independently of chronic inflammation, suggesting increased body iron stores in these women very especially when obesity is also present [7]. Furthermore, our recent results strongly suggest that insulin resistance and hyperinsulinism, and not the reduced menstrual losses derived from oligomenorrhea or mutations in the hemochromatosis HFE gene, underlie the origin of these increased body iron stores [11], [12].
###end p 10
###begin p 11
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-FernandezReal1">[13]</xref>
###xml 332 336 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
###xml 664 668 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
###xml 886 890 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
But iron metabolism is a complex system in which protection against iron losses and against the oxidative damage caused by free iron radicals are predominant mechanisms [13]. Haptoglobin, a circulating acute-phase protein that is synthesized in the liver under the influence of several cytokines such as TNF-alpha and interleukin-6 [14], ameliorates the iron loss and renal injury that follows the liberation of hemoglobin from erythrocytes during processes of intravascular hemolysis. Haptoglobin accomplishes this function by forming soluble complexes with hemoglobin, thereby reducing the generation of oxygen reactive species and ameliorating oxidative stress [14]. Also, haptoglobin inhibits the synthesis of prostaglandins and the vasodilation mediated by nitric oxide, and exerts immunomodulatory actions by its binding to the CD163 receptor present in macrophages and monocytes [14].
###end p 11
###begin p 12
###xml 262 263 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 260 263 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>1</sup></italic>
###xml 270 271 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 268 271 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 271 275 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Bowman1">[15]</xref>
###xml 360 364 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
###xml 372 373 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 376 377 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 370 377 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 617 621 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Asleh1">[16]</xref>
###xml 56 62 <span type="species:ncbi:9606">humans</span>
The molecular structure of haptoglobin is determined in humans by the existence of a polymorphism affecting the gene on chromosome 16q22 that encodes the alpha chain of this globulin. This polymorphism results in the existence of two different alleles, termed Hp1 and Hp2[15] that may be explored by DNA genotyping or by plasma gel electrophoresis phenotyping [14]. The Hp2/Hp2 genotype = Hp 2-2 phenotype reduces plasma haptoglobin levels, decreases its hemoglobin-binding capacity and anti-oxidant properties and the secretion of anti-inflammatory cytokines such as IL-10, while increasing immunological reactivity [16].
###end p 12
###begin p 13
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-FernandezReal1">[13]</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois2">[17]</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Chiellini1">[18]</xref>
###xml 783 787 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-MatharooBall1">[19]</xref>
###xml 789 793 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Insenser1">[20]</xref>
###xml 268 271 <span type="species:ncbi:9606">Men</span>
###xml 376 379 <span type="species:ncbi:9606">men</span>
Furthermore, haptoglobin phenotypes influence serum ferritin concentrations, and increased ferritin concentrations have been described not only in PCOS, but also in insulin resistant disorders such as obesity, type 2 diabetes mellitus and the metabolic syndrome [13]. Men expressing the Hp 2-2 phenotype present with increased serum ferritin concentrations when compared with men expressing the Hp 2-1 and Hp 1-1 phenotypes [17]. Haptoglobin is expressed in adipocytes [18] and, because serum haptoglobin concentrations correlate with increasing body weight, its circulating concentrations are increasingly being considered as a marker of adiposity. Finally, a recent proteomic analysis of serum has identified both the alpha and beta haptoglobin chains as potential PCOS biomarkers [19], [20].
###end p 13
###begin p 14
Therefore, we conducted the present study hypothesizing that haptoglobin and its polymorphism might mediate the associations of PCOS with hyperferritinemia and increased body iron stores, obesity and disorders of glucose tolerance.
###end p 14
###begin title 15
Materials and Methods
###end title 15
###begin title 16
Ethics statement
###end title 16
###begin p 17
###xml 51 63 <span type="species:ncbi:9606">participants</span>
Written informed consent was obtained from all the participants and the study was approved by the Clinical Research Ethics Committee of Hospital Universitario Ramon y Cajal.
###end p 17
###begin title 18
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants
###end title 18
###begin p 19
###xml 629 632 629 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Azziz1">[1]</xref>
###xml 634 637 634 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Azziz2">[2]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Zawadzki1">[21]</xref>
###xml 728 731 728 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-AlvarezBlasco1">[6]</xref>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 250 258 <span type="species:ncbi:9606">patients</span>
###xml 297 302 <span type="species:ncbi:9606">women</span>
###xml 866 871 <span type="species:ncbi:9606">women</span>
###xml 1083 1091 <span type="species:ncbi:9606">patients</span>
We studied serum haptoglobin concentrations and haptoglobin genotypes in a large series of obese and non-obese PCOS patients and non-hyperandrogenic controls presenting with or without abnormalities of glucose tolerance. The sample included 141 PCOS patients and 102 non-hyperandrogenic Caucasian women prospectively recruited at the Department of Endocrinology of Hospital Universitario Ramon y Cajal, a tertiary care academic hospital affiliated with the University of Alcala. The diagnosis of PCOS relied on the presence of oligo-ovulation and clinical and/or biochemical hyperandrogenism, after excluding specific etiologies [1], [2], [21]. The particular methods used to establish these criteria have been reported earlier [6]. The non-hyperandrogenic control group was composed of normal weight healthy female volunteers and of consecutive overweight or obese women, who did not have any known metabolic comorbidity, reporting to the clinical practice of the authors solely for treatment of weight excess. Controls were selected in order to be similar in terms of BMI with the patients. None of the controls had signs or symptoms of hyperandrogenism, menstrual dysfunction, or history of infertility.
###end p 19
###begin p 20
###xml 93 94 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 123 124 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 219 223 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Flegal1">[22]</xref>
###xml 42 47 <span type="species:ncbi:9606">women</span>
According to their body mass index (BMI), women were classified as being obese (BMI>/=30 kg/m2) or non-obese (BMI<30.0 kg/m2), because only obesity - and not overweight - has demonstrated a negative impact on mortality [22].
###end p 20
###begin p 21
###xml 12 24 <span type="species:ncbi:9606">participants</span>
None of the participants had a personal history of hypertension, regular alcohol consumption, disorders of glucose tolerance, hyperuricemia, cardiovascular events, sleep apnea, or had received treatment with oral contraceptives, antiandrogens or insulin sensitizers for the previous 6 months.
###end p 21
###begin title 22
Study protocol and assays
###end title 22
###begin p 23
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-AlvarezBlasco1">[6]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Vermeulen1">[23]</xref>
###xml 279 291 <span type="species:ncbi:9606">participants</span>
Clinical and anthropometrical variables, including the hirsutism score, BMI and waist-to-hip ratio were determined as reported previously [6]. Blood samples were obtained between days five and 10 of the menstrual cycle, or during amenorrhea after excluding pregnancy, in all the participants. After a three-day 300-g carbohydrate diet and 12-h overnight fasting, samples were obtained early in the morning for the measurement of haptoglobin, ferritin, C-reactive protein, total testosterone, sex hormone-binding globulin and calculated free testosterone [23], androstenedione, estradiol, dehydroepiandrosterone-sulfate, 17-hydroxyprogesterone, prolactin, thyrotropin, luteinizing hormone and follicle-stimulating hormone. Complete serum biochemistry and lipid profiles were also obtained. Then, a 75-g oral glucose tolerance test was performed, and samples were obtained for measurement of serum insulin and plasma glucose at 0, 30, 60, 90 and 120 min. Samples were immediately centrifuged, and serum and plasma were separated and frozen at -30 C until assayed.
###end p 23
###begin p 24
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Dati1">[24]</xref>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Koch1">[25]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
The circulating concentrations of haptoglobin were assayed by a commercial immunonephelometry method (Dade Behring, Marburg, Alemania) calibrated against the international CRM 470 reference material [24] with intraassay and interassay CV of 2.6% and 6.2%, respectively. Haptoglobin genotypes were estimated using the PCR-based technique previously described by Koch et al.[25]. For plasma haptoglobin levels, we used the normal ranges established internationally for each particular haptoglobin genotype/phenotype [14].
###end p 24
###begin p 25
Serum ferritin and C-reactive protein concentrations were measured by automated immunochemiluminescence (Immulite 2000 Ferritin and High Sensitivity CRP, Diagnostic Products Corporation, Los Angeles, CA) with lower limit of detection of 0.88 pmol/l and 0.1 mg/l respectively, and intra- and inter-assay coefficients of variation below 10%.
###end p 25
###begin p 26
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-AlvarezBlasco1">[6]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Matsuda1">[26]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-American1">[27]</xref>
###xml 362 367 <span type="species:ncbi:9606">women</span>
The technical characteristics of the assays employed for plasma glucose concetrations, lipid profiles and serum hormone measurements have been described elsewhere [6]. The composite insulin sensitivity index was calculated from the circulating glucose and insulin concentrations during the oral glucose tolerance test according to Matsuda and DeFronzo [26], and women were classified as having normal or abnormal glucose tolerance (impaired fasting glucose, impaired glucose tolerance or diabetes) according to the American Diabetes Association clinical practice recommendations [27].
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
###xml 215 216 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The results are reported as mean+/-standard deviation unless otherwise stated. The association of the haptoglobin genomic variants with PCOS, obesity and abnormalities of glucose tolerance was explored using the chi2 or Fisher's exact test as appropriate. The Kolmogorov-Smirnov statistic was applied to continuous variables. Logarithmic or square root transformations were applied as needed to ensure normal distribution of the variables, and parametric tests were applied thereafter. Mathematical transformation was not applied to serum haptoglobin levels, because this variable was normally distributed.
###end p 28
###begin p 29
General linear models adjusting for age served to evaluate the impact of PCOS on clinical and biochemical variables. General linear models introducing the haptoglobin genotype, obesity and glucose tolerance as independent variables, were used to study their influence on phenotypic variables.
###end p 29
###begin p 30
###xml 297 299 293 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp</italic>
###xml 322 323 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 320 323 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>1</sup></italic>
###xml 326 327 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 324 327 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>1</sup></italic>
###xml 335 336 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 339 340 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 333 340 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>1</sup></italic>
###xml 351 352 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 355 356 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 349 356 345 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 587 588 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
A multiple linear regression model with stepwise (probability of F to enter</=0.05, probability of F to remove>/=0.10) introduction of age, BMI, waist-to-hip ratio, presence or absence of PCOS, serum C-reactive protein, ferritin and free testosterone concentrations, insulin sensitivity index and Hp genotypes (coded as Hp1/Hp1 = 0, Hp2/Hp1 = 1 and Hp2/Hp2 = 2) as independent variables, was used to evaluate the contribution of these variables to the variability in serum haptoglobin concentrations. Analyses were performed using SPSS10 for the Macintosh (SPSS Inc, Chicago, Illinois). P<0.05 was considered statistically significant.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Comparison of clinical, biochemical and metabolic variables among patients and controls
###end title 32
###begin p 33
###xml 209 216 209 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t001">Table 1</xref>
###xml 284 286 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 315 316 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
As expected by design the patients with PCOS and the non-hyperandrogenic controls showed no statistically significant differences in the mean BMI or in the distribution according to the weight classification (Table 1), yet because PCOS patients were younger than controls (25.4+/-6.3 vs 31.7+/-7.7 yr respectively, P = 0.001), age was introduced as a covariate in the following analyses.
###end p 33
###begin title 34
###xml 21 29 <span type="species:ncbi:9606">patients</span>
Distribution of PCOS patients and controls according to their weight classification.
###end title 34
###begin p 35
###xml 47 48 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 77 78 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 5 <span type="species:ncbi:9606">Women</span>
Women were classified into obese (BMI>/=30 kg/m2) or non-obese (BMI<30.0 kg/m2) subgroups according to their BMI.
###end p 35
###begin p 36
###xml 129 130 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 140 141 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 180 181 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
No differences were observed between PCOS patients and controls in the distribution according to their weight classification (chi2 = 2.347, P = 0.126), or in their BMI (F = 1.580, P = 0.210).
###end p 36
###begin p 37
###xml 262 269 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t002">Table 2</xref>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 406 414 <span type="species:ncbi:9606">patients</span>
PCOS patients presented with increased hirsutism scores, waist-to-hip ratio, fasting insulin and triglycerides, serum concentrations of total and free testosterone, androstenedione, 17-hydroxyprogesterone, dehydroepiandrosterone-sulfate and luteinizing-hormone (Table 2). On the contrary, the insulin sensitivity index as well as serum sex hormone-binding globulin and estradiol levels were reduced in the patients. Furthermore, there were no differences in the frequency of smoking or of abnormal glucose tolerance.
###end p 37
###begin title 38
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 90 95 <span type="species:ncbi:9606">women</span>
Clinical and biochemical characteristics of PCOS patients and non-hyperandrogenic control women.
###end title 38
###begin p 39
###xml 214 222 <span type="species:ncbi:9606">patients</span>
Results are means+/-SD or raw numbers and percentages. Continuous variables were submitted to a general linear model in which age was introduced as a covariate to correct for the difference in age observed between patients and controls. Categorical variables were submitted to Fisher's exact test.
###end p 39
###begin title 40
Haptoglobin and PCOS
###end title 40
###begin p 41
###xml 106 113 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t002">Table 2</xref>
###xml 330 331 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 341 342 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 146 151 <span type="species:ncbi:9606">women</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
Serum haptoglobin concentrations were not different among PCOS patients and non-hyperandrogenic controls (Table 2). Furthermore, the frequency of women presenting with serum haptoglobin concentrations above the references values for their haptoglobin genotype was similar in both groups (controls 25.5% vs PCOS patients 26.1%, chi2 = 0.010, P = 0.921).
###end p 41
###begin p 42
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 174 177 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 233 234 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 244 245 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 333 334 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 337 338 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 331 338 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 385 386 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 389 390 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 383 390 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>1</sup>/Hp<sup>1</sup></italic>
###xml 446 453 444 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t003">Table 3</xref>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 409 417 <span type="species:ncbi:9606">patients</span>
After confirming that the haptoglobin genotype was distributed according to Hardy-Weinberg equilibrium in both PCOS patients and controls (data not shown), we found that the Hp2 allele was more frequent in the former (62% vs 52%, chi2 = 5.191, P = 0.023), explaining a borderline significant tendency towards a higher frequency of Hp2/Hp2 genotype, and to a reduced frequency of the Hp1/Hp1 genotype, in PCOS patients compared with the controls (Table 3).
###end p 42
###begin title 43
Distribution of haptoglobin genotypes in the presence or absence of PCOS, obesity, or disordered glucose tolerance.
###end title 43
###begin p 44
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>1</sup>/Hp<sup>1</sup></italic>
###xml 211 212 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 222 223 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 244 245 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 255 256 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 290 291 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 301 302 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
There was a borderline significant tendency towards an increased frequency of Hp2/Hp2 genotype, and a decreased frequency of the Hp1/Hp1 genotype, in PCOS patients compared with non-hyperandrogenic controls (chi2 = 5.220, P = 0.074 overall; chi2 = 3.650, P = 0.056 for a dominant model; chi2 = 3.521, P = 0.061 for a recessive model).
###end p 44
###begin p 45
###xml 169 170 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 180 181 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 225 226 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 236 237 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 107 112 <span type="species:ncbi:9606">women</span>
There were no statistically significant differences in the distribution of haptoglobin genotypes among the women classified according to their weight classification (chi2 = 0.082, P = 0.960) or to their glucose tolerance (chi2 = 2.610, P = 0.271).
###end p 45
###begin p 46
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 158 159 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 152 159 152 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>1</sup></italic>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 164 171 164 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>1</sup>/Hp<sup>1</sup></italic>
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005606-g001">Figure 1</xref>
###xml 424 431 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t002">Table 2</xref>
###xml 27 32 <span type="species:ncbi:9606">women</span>
###xml 131 136 <span type="species:ncbi:9606">women</span>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
Finally, we confirmed that women with the Hp2/Hp2 genotype had mildly reduced circulating haptoglobin concentrations compared with women presenting the Hp2/Hp1 and Hp1/Hp1 genotypes (Figure 1) yet the 10% difference in the frequencies of haptoglobin genotypes among patients and controls, although statistically significant, was not large enough to cause an actual difference in their mean serum haptoglobin concentrations (Table 2).
###end p 46
###begin title 47
Serum haptoglobin, C-reactive protein and ferritin concentrations as a function of the haptoglobin genotype, obesity and glucose tolerance.
###end title 47
###begin p 48
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 172 173 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 235 236 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 215 220 <span type="species:ncbi:9606">women</span>
###xml 258 263 <span type="species:ncbi:9606">women</span>
Data are means and 95% confidence intervals. The numbers below the x-axis are the number of subjects in each subgroup. *P<0.05 or less between haptoglobin genotypes; daggerP<0.05 or less between obese and non-obese women. double daggerP<0.05 or less between women with normal or abnormal glucose tolerance.
###end p 48
###begin title 49
Haptoglobin and obesity
###end title 49
###begin p 50
###xml 84 92 84 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005606-g001">Figure 1</xref>
###xml 307 308 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 318 319 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 49 54 <span type="species:ncbi:9606">women</span>
###xml 114 119 <span type="species:ncbi:9606">women</span>
###xml 173 178 <span type="species:ncbi:9606">women</span>
###xml 291 296 <span type="species:ncbi:9606">women</span>
Serum haptoglobin levels were increased in obese women irrespective of PCOS status (Figure 1). Accordingly, obese women presented with a 5-fold increase in the frequency of women presenting with elevated serum haptoglobin concentrations for their haptoglobin genotype (non-obese 8.7%, obese women 44.1%, chi2 = 39.73, P<0.001).
###end p 50
###begin p 51
###xml 198 205 198 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t003">Table 3</xref>
###xml 191 196 <span type="species:ncbi:9606">women</span>
Of note, the increase in serum haptoglobin concentrations with obesity was unrelated to the haptoglobin polymorphism, because its genotypes were equally distributed among non-obese and obese women (Table 3).
###end p 51
###begin title 52
Haptoglobin and abnormalities of glucose tolerance
###end title 52
###begin p 53
###xml 136 144 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005606-g001">Figure 1</xref>
###xml 373 374 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 383 384 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 513 520 511 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t003">Table 3</xref>
###xml 57 62 <span type="species:ncbi:9606">women</span>
Serum haptoglobin concentrations were not different when women were classified according to their normal or abnormal glucose tolerance (Figure 1), and the frequency of subjects presenting with increased serum haptoglobin levels for their genotype were not different depending on their glucose tolerance (normal glucose tolerance 24.0%, abnormal glucose tolerance 33.3%, chi2 = 1.844 P = 0.174). Finally, haptoglobin genotypes were similarly distributed among the groups with normal or abnormal glucose tolerance (Table 3).
###end p 53
###begin title 54
Impact of the haptoglobin polymorphism, PCOS, obesity and abnormalities of glucose tolerance on serum ferritin and C-reactive protein concentrations
###end title 54
###begin p 55
###xml 97 105 97 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005606-g001">Figure 1</xref>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t002">Table 2</xref>
###xml 294 302 294 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005606-g001">Figure 1</xref>
###xml 376 384 376 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005606-g001">Figure 1</xref>
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 602 610 602 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005606-g001">Figure 1</xref>
###xml 669 676 669 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005606-t002">Table 2</xref>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 252 257 <span type="species:ncbi:9606">women</span>
###xml 287 292 <span type="species:ncbi:9606">women</span>
###xml 326 331 <span type="species:ncbi:9606">women</span>
###xml 463 468 <span type="species:ncbi:9606">women</span>
###xml 552 557 <span type="species:ncbi:9606">women</span>
###xml 662 667 <span type="species:ncbi:9606">women</span>
The haptoglobin genotype did not influence serum ferritin and C-reactive protein concentrations (Figure 1). Serum ferritin concentrations were higher in PCOS patients when compared with non-hyperandrogenic controls (Table 2), were also higher in obese women when compared with non-obese women (Figure 1), and increased in the women presenting with abnormal glucose tolerance (Figure 1). On the contrary, serum C-reactive protein concentrations increased in obese women compared to their non-obese counterparts and tended to increase (P = 0.079) in the women presenting with abnormal glucose tolerance (Figure 1), but were similar in PCOS and non-hyperandrogenic women (Table 2).
###end p 55
###begin title 56
###xml 58 63 <span type="species:ncbi:9606">women</span>
Determinants of serum haptoglobin levels in premenopausal women
###end title 56
###begin p 57
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 225 226 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 254 255 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 264 266 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp</italic>
###xml 293 294 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 348 349 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
A multiple regression model (R2 = 0.498, F = 58.6, P<0.0001) demonstrated that 50% of the variation in serum haptoglobin concentrations was explained by the variation in serum C-reactive protein concentrations (beta = 0.405, P<0.001), BMI (beta = 0.251, P<0.001), Hp genotypes (beta = -0.207, P<0.001) and insulin sensitivity index (beta = -0.167, P = 0.001). Age, PCOS, waist-to-hip ratio, ferritin and free testosterone concentrations were excluded by the stepwise regression model.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 383 390 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 229 234 <span type="species:ncbi:9606">women</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
To our best knowledge, we here present the first data regarding serum haptoglobin concentrations and its genotypes in patients with PCOS. The most important finding of our present study is that, compared with non-hyperandrogenic women, PCOS patients presented with an increased frequency of the Hp2 allele (and a borderline significant tendency towards an increased frequency of the Hp2/Hp2 genotype).
###end p 59
###begin p 60
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Legro1">[10]</xref>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
The importance of the association of PCOS with Hp2 alleles is that this polymorphism influences the functional properties of haptoglobin in a way that might contribute to the known clustering of cardiovascular risk factors in PCOS patients [10] even in the absence of actual differences in serum haptoglobin levels.
###end p 60
###begin p 61
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 228 229 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
###xml 439 440 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 437 444 437 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
###xml 536 537 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 534 537 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Kelly1">[28]</xref>
###xml 684 687 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Sabuncu1">[9]</xref>
###xml 558 566 <span type="species:ncbi:9606">patients</span>
###xml 697 702 <span type="species:ncbi:9606">women</span>
###xml 778 783 <span type="species:ncbi:9606">women</span>
On the one hand, the haptoglobin polymorphism causes a gene-dosage effect resulting in a graded decrease in the haptoglobin ability to bind hemoglobin, in the antioxidant capacity and in prostaglandin inhibition, with the Hp2/Hp2 genotype expressing the weakest protein activities [14]. On the other hand, the haptoglobin polymorphism also results in a graded increase in the angiogenic and inflammatory effects of haptoglobin, with the Hp2/Hp2 genotype expressing the strongest properties [14]. Therefore, the increased frequency of Hp2 alleles in our PCOS patients might also play a role in the previously reported low-grade chronic inflammation [28] and increased oxidative stress [9] of these women, even when serum haptoglobin concentrations were not altered in these PCOS women.
###end p 61
###begin p 62
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Levy1">[29]</xref>
###xml 465 466 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 469 470 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 463 470 463 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 526 528 526 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp</italic>
###xml 545 547 545 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp</italic>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Levy2">[30]</xref>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Christian1">[31]</xref>
###xml 916 920 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-LuqueRamirez2">[32]</xref>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 430 436 <span type="species:ncbi:10090">murine</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 512 518 <span type="species:ncbi:10090">murine</span>
###xml 764 772 <span type="species:ncbi:9606">patients</span>
Supporting a role for the haptoglobin polymorphism in the development of atherosclerotic disease and cardiovascular events, the Hp 2-2 phenotype increases the risk for micro- and macrovascular complications in diabetic patients [29] possibly because this phenotype facilitates the generation of reactive oxygen species, and oxidative stress is involved in myocardial damage and atherosclerosis. Furthermore, in the ApoE knock-out murine model of atherosclerosis, Hp2/Hp2 mice obtained by targeted insertion of a murine type 2 Hp allele into the Hp locus by homologous recombination show increased iron deposition, lipid peroxidation and macrophage accumulation within atherosclerotic plaque, increasing the risk of rupture and thrombosis [30]. Interestingly, PCOS patients show early markers of atherosclerosis such as increased carotid intima-media thickness and coronary artery calcification from young ages [31], [32].
###end p 62
###begin p 63
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 273 281 <span type="species:ncbi:9606">patients</span>
Of note, the difference in the frequency of haptoglobin genotypes was actually caused by a relatively low frequency of Hp2 alleles in the controls when compared to that found in the general population of other countries whereas, on the contrary, the frequency found in the patients was similar to that reported in other Caucasians populations.
###end p 63
###begin p 64
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 512 514 512 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp</italic>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
This surprising finding has two possible explanations: first, the frequencies of haptoglobin alleles in the Spanish population has not been established, and may be lower compared with those found in other European controls. Second, our controls were selected as to have no known metabolic or hyperandrogenic disorder, and considering the high prevalences of these conditions in the general population, this selection bias may explain a reduced frequency of Hp2 alleles in them. Nevertheless, the distribution of Hp alleles was in Hardy-Weimberg equilibrium in both PCOS patients and in controls, ruling out significant population stratification in our series.
###end p 64
###begin p 65
###xml 171 175 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
###xml 232 233 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 230 233 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 388 389 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 386 389 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 595 599 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-DePergola1">[33]</xref>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 471 476 <span type="species:ncbi:9606">women</span>
The alpha chain haptoglobin polymorphism influences circulating haptoglobin concentrations to a lesser degree compared with its impact on the functionality of the protein [14]. This may explain why PCOS patients, despite carrying Hp2 alleles more frequently than controls, did not have reduced serum haptoglobin levels. Also, the lowering effect on serum haptoglobin levels of carrying Hp2 alleles may have been obscured in the PCOS patients presented here because these women were insulin resistant compared with the controls, and insulin resistance actually increases serum haptoglobin levels [33] as our data also demonstrate.
###end p 65
###begin p 66
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois2">[17]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Moirand1">[34]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-LuqueRamirez1">[12]</xref>
###xml 1015 1019 1015 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-EscobarMorreale4">[35]</xref>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
###xml 202 210 <span type="species:ncbi:9606">patients</span>
###xml 462 470 <span type="species:ncbi:9606">patients</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
###xml 700 705 <span type="species:ncbi:9606">women</span>
Our present results do not suggest that the haptoglobin polymorphism influences the increased serum ferritin concentrations of PCOS patients, in sharp contrast with the findings in male hemochromatosis patients, in whom the Hp 2-2 phenotype increases iron overload and the expression of the hemochromatosis phenotype [17]. Although the ferritin lowering effect of regular menstrual iron losses [34] might contribute to explain this discrepancy, most of the PCOS patients had chronic oligomenorrhea, and our previous studies on PCOS patients suggest that insulin resistance, and not genetic factors, is one of the major determinants of increased serum ferritin concentrations and iron stores in these women [12]. Similarly, the haptoglobin polymorphism did not influence serum C-reactive protein concentrations in our population, yet the possible effect of the polymorphism on local inflammatory mechanisms may have been obscured by the strongest influence of obesity on the serum levels of this inflammatory marker [35].
###end p 66
###begin p 67
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Chiellini1">[18]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Delanghe1">[36]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Chiellini1">[18]</xref>
###xml 233 238 <span type="species:ncbi:9606">women</span>
The impact of weight excess on serum haptoglobin concentrations and the other circulating inflammatory markers studied here merits further comment. Our present results indicate that serum haptoglobin concentration, and the number of women presenting with serum levels above the upper limit of the normal range, increase with obesity. These results confirm the previously reported association of circulating haptoglobin concentrations with BMI [18], [36], which might be dependent on the expression of haptoglobin in adipose tissue [18]. Furthermore, obesity also increases serum C-reactive protein and ferritin concentrations pointing to the existence of chronic inflammation and increased body iron stores in obesity and other disorders characterized by the presence of insulin resistance.
###end p 67
###begin p 68
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Chiellini1">[18]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-DePergola1">[33]</xref>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Delanghe1">[36]</xref>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-FernandezReal1">[13]</xref>
###xml 263 268 <span type="species:ncbi:9606">women</span>
###xml 658 663 <span type="species:ncbi:9606">women</span>
###xml 846 851 <span type="species:ncbi:9606">women</span>
Even when serum haptoglobin levels increase with insulin resistance and obesity [18], [33], [36], neither serum haptoglobin levels nor the haptoglobin genotype were related to the development of disorders of glucose tolerance in our series of young premenopausal women. Therefore, haptoglobin does not appear to be involved in the failure of compensatory endogenous hyperinsulinism to maintain glycemia within the normal range, which is the hallmark of abnormal glucose tolerance in insulin resistant subjects. On the contrary, increased body iron stores may have contributed to this failure [13], because serum ferritin levels were clearly increased in the women who had abnormal glucose tolerance in our series. Of note, chronic inflammation might play a similar role, yet the tendency towards an increase in serum C-reactive protein levels in women presenting with abnormal glucose tolerance did not reach statistical significance.
###end p 68
###begin p 69
Our study was limited, however, by a relatively low statistical power for detection of differences between the small subgroups resulting from categorization by presence or absence of metabolic traits. This limitation was especially evident when considering glucose tolerance, and therefore a possible influence of haptoglobin levels or genotypes on the development of disorders of glucose tolerance cannot be definitely excluded by our present results.
###end p 69
###begin p 70
###xml 678 679 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 682 683 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 676 683 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup>/Hp<sup>2</sup></italic>
###xml 824 828 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005606-Langlois1">[14]</xref>
###xml 134 139 <span type="species:ncbi:9606">women</span>
###xml 778 783 <span type="species:ncbi:9606">women</span>
Finally, the results of the multiple regression model indicates that serum haptoglobin concentrations are determined in premenopausal women by several factors including BMI, serum C-reactive protein concentrations and the insulin sensitivity index, in addition to haptoglobin genotypes. Overall, the result of the regression analysis suggests that adipose tissue, and also the chronic inflammatory milieu (possibly reflecting the action of inflammatory cytokines such as TNF-alpha and IL-6 on the liver) and the insulin resistant state associated with obesity, up-regulate haptoglobin secretion contributing to its circulating concentrations. On the contrary, the haptoglobin Hp2/Hp2 genotype resulted in a mild decrease in serum haptoglobin concentrations in our premenopausal women, as has been shown in other populations [14].
###end p 70
###begin p 71
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hp<sup>2</sup></italic>
###xml 142 147 <span type="species:ncbi:9606">women</span>
###xml 416 421 <span type="species:ncbi:9606">women</span>
In summary, the association of PCOS with Hp2 alleles of haptoglobin suggests that the functionality of this protein might be altered in these women, even when its circulating concentrations are not altered because their insulin resistance counteracts the decrease in circulating haptoglobin usually associated with Hp2 alleles. Also, our present results indicate that serum haptoglobin levels of young premenopausal women are mostly dependent on the haptoglobin polymorphism and on obesity, with insulin resistance and chronic inflammation possibly contributing to this association.
###end p 71
###begin p 72
We thank Ms. Genoveva Gonzalez from the Laboratory of the Department of Endocrinology of Hospital Ramon y Cajal, for excellent technical help.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
###end article-title 74
###begin article-title 75
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
###end article-title 75
###begin article-title 76
###xml 66 71 <span type="species:ncbi:9606">women</span>
High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
###end article-title 76
###begin article-title 77
###xml 57 62 <span type="species:ncbi:9606">women</span>
Hyperandrogenism and polycystic ovary syndrome (PCOS) in women with type 1 diabetes mellitus.
###end article-title 77
###begin article-title 78
###xml 40 45 <span type="species:ncbi:9606">women</span>
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
###end article-title 78
###begin article-title 79
###xml 88 93 <span type="species:ncbi:9606">women</span>
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
###end article-title 79
###begin article-title 80
###xml 55 60 <span type="species:ncbi:9606">women</span>
Body iron stores are increased in overweight and obese women with polycystic ovary syndrome.
###end article-title 80
###begin article-title 81
The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.
###end article-title 81
###begin article-title 82
Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease.
###end article-title 82
###begin article-title 83
Polycystic ovary syndrome and cardiovascular disease: a premature association?
###end article-title 83
###begin article-title 84
###xml 137 142 <span type="species:ncbi:9606">women</span>
Mutations in the hereditary hemochromatosis gene are not associated with the increased body iron stores observed in overweight and obese women with polycystic ovary syndrome.
###end article-title 84
###begin article-title 85
###xml 40 45 <span type="species:ncbi:9606">women</span>
The increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism, and do not result from reduced menstrual losses.
###end article-title 85
###begin article-title 86
Cross-talk between iron metabolism and diabetes.
###end article-title 86
###begin article-title 87
###xml 68 74 <span type="species:ncbi:9606">humans</span>
Biological and clinical significance of haptoglobin polymorphism in humans.
###end article-title 87
###begin article-title 88
Haptoglobin.
###end article-title 88
###begin article-title 89
Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
###end article-title 89
###begin article-title 90
The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males.
###end article-title 90
###begin article-title 91
###xml 50 56 <span type="species:ncbi:9606">humans</span>
Serum haptoglobin: a novel marker of adiposity in humans.
###end article-title 91
###begin article-title 92
Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms.
###end article-title 92
###begin article-title 93
Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach.
###end article-title 93
###begin article-title 94
Excess deaths associated with underweight, overweight, and obesity.
###end article-title 94
###begin article-title 95
A critical evaluation of simple methods for the estimation of free testosterone in serum.
###end article-title 95
###begin article-title 96
Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470).
###end article-title 96
###begin article-title 97
Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR.
###end article-title 97
###begin article-title 98
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.
###end article-title 98
###begin article-title 99
Diagnosis and Classification of Diabetes Mellitus.
###end article-title 99
###begin article-title 100
###xml 34 39 <span type="species:ncbi:9606">women</span>
Low grade chronic inflammation in women with polycystic ovarian syndrome.
###end article-title 100
###begin article-title 101
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Haptoglobin phenotype and vascular complications in patients with diabetes.
###end article-title 101
###begin article-title 102
Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque.
###end article-title 102
###begin article-title 103
###xml 62 67 <span type="species:ncbi:9606">women</span>
Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.
###end article-title 103
###begin article-title 104
###xml 98 103 <span type="species:ncbi:9606">women</span>
Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome (PCOS).
###end article-title 104
###begin article-title 105
###xml 95 100 <span type="species:ncbi:9606">women</span>
Haptoglobin serum levels are independently associated with insulinemia in overweight and obese women.
###end article-title 105
###begin article-title 106
###xml 48 53 <span type="species:ncbi:9606">women</span>
###xml 68 71 <span type="species:ncbi:9606">men</span>
Clinical features of genetic hemochromatosis in women compared with men.
###end article-title 106
###begin article-title 107
###xml 130 135 <span type="species:ncbi:9606">women</span>
Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.
###end article-title 107
###begin article-title 108
Discriminative value of serum amyloid A and acute-phase proteins for coronary heart disease.
###end article-title 108
###begin p 109
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 109
###begin p 110
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, grant FIS PI080944. CIBERDEM is an initiative of Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 110

